MedDataX Logo

Ambulatory Versus Home Blood Pressure Measurement

NCT ID: NCT01132001

Last Updated: 2012-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-10-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective study comparing the three blood pressure monitoring methods on the diagnosis of arterial hypertension. Blood pressure of each subject will be evaluated with clinic, home and 24h ambulatory blood pressure measurements in three visits

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arterial Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 20 yrs
* Patients referred to an outpatient clinic for high blood pressure
* Patients with no treatment or with antihypertensive treatment stable for at least 4 weeks.
* Patients capable of performing home blood pressure measurements.
* Signed informed consent

Exclusion Criteria

* Hypertension stage III (SBP\>180 mmHg or DBP\>110mmHg)
* Secondary hypertension
* Resistant hypertension
* Arrhythmia
* Pregnancy
* Symptomatic heart disease
* Renal disease (Cr\>2mg/dl)
* Uncontrolled diabetes mellitus (HbA1c\>8.5%)
Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Athens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

George S. Stergiou

Associate Professor of Medicine and Hypertension

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

George S Stergiou, MD

Role: STUDY_CHAIR

Hypertension Center,Third Department of Medicine,University of Athens,Greece

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hypertension Center, Third Department of Medicine, University of Athens, Greece

Athens, , Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

George S Stergiou, MD

Role: CONTACT

Phone: +302107763117

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

George S Stergiou, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HBP5

Identifier Type: -

Identifier Source: org_study_id